Literature DB >> 29740803

Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Alleviates Lead Acetate-Induced Bone Loss in Rats.

Shanshan Qi1, Hongxing Zheng2, Chen Chen3,4, Hai Jiang5.   

Abstract

The purpose of this study was to evaluate the protective effect of Du-Zhong cortex extract (DZCE) on lead acetate-induced bone loss in rats. Forty female Sprague-Dawley rats were randomly divided into four groups: group I (control) was provided with distilled water. Group II (PbAc) received 500 ppm lead acetate in drinking water for 60 days. Group III (PbAc+DZCE) received 500 ppm lead acetate in drinking water, and given intragastric DZCE (100 mg/kg body weight) for 60 days. Group IV (DZCE) was given intragastric DZCE (100 mg/kg body weight) for 60 days. The bone mineral density, serum biochemical markers, bone histomorphology, and bone marrow adipocyte parameters were analyzed using dual-energy X-ray absorptiometry, biochemistry, histomorphometry, and histopathology, respectively. The results showed that the lumbar spine and femur bone mineral density was significantly decreased in PbAc group compared with the control (P < 0.05); however, this decrease was inhibited by the intake of Du-Zhong cortex extract (P < 0.05, vs. PbAc group; P > 0.05, vs. control and DZCE group). Serum calcium and serum phosphorus in the PbAc+DZCE group were greater than that in the PbAc group (P < 0.05). The PbAc group had higher ALP, osteocalcin, and RANKL than the control group (P < 0.01), and they were significantly lower in the PbAc+DZCE group compared with the PbAc group. There were no significant differences of ALP, osteocalcin, and RANKL among the PbAc+DZCE, control, and DZCE groups (P > 0.05). Serum OPG and OPG/RANKL ration were significantly higher in the PbAc+DZCE group than that in the PbAc group (P < 0.05). The bone histomorphometric analyses showed that bone volume and trabecular thickness in the femoral trabecular bone were significantly lower in the PbAc group than that in the control group, but those were restored in the PbAc+DZCE groups. The bone marrow adipocyte number, percent adipocyte volume per tissue volume (AV/TV), and mean adipocyte diameter were significantly increased in the PbAc group compared to the control (P < 0.01), and those were restored in the PbAc+DZCE group. The differences of those parameters between PbAc+DZCE, DZCE, and the control group were not significant. The results above indicate that the Du-Zhong cortex extract has protective effects on both stimulation of bone formation and suppression of bone resorption in lead-exposed rats, therefore, Du-Zhong cortex extract has the potential to prevent or treat osteoporosis resulting from lead expose.

Entities:  

Keywords:  BMD; Bone histomorphology; Eucommia ulmoides Oliv; Lead; Rats

Mesh:

Substances:

Year:  2018        PMID: 29740803     DOI: 10.1007/s12011-018-1362-6

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  8 in total

1.  Allicin Alleviates Lead-Induced Bone Loss by Preventing Oxidative Stress and Osteoclastogenesis Via SIRT1/FOXO1 Pathway in Mice.

Authors:  Dong Li; Haipeng Liang; Yuan Li; Jianhui Zhang; Liang Qiao; Huayun Luo
Journal:  Biol Trace Elem Res       Date:  2020-04-21       Impact factor: 3.738

Review 2.  Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer's Disease Complicated With Osteoporosis.

Authors:  Weifan Xu; Yiping Jiang; Nani Wang; Huanhuan Bai; Shengyan Xu; Tianshuang Xia; Hailiang Xin
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

3.  Network pharmacology explores the mechanisms of Eucommia ulmoides cortex against postmenopausal osteoporosis.

Authors:  Yan Shao; Song Chen; Ke Zhou; Kaifeng Gan; Jin Li; Chenjie Xia
Journal:  Medicine (Baltimore)       Date:  2022-05-13       Impact factor: 1.817

4.  Decreased fracture incidence with traditional Chinese medicine therapy in patients with osteoporosis: a nationwide population-based cohort study.

Authors:  Yu-Chi Wang; Jen-Huai Chiang; Hsin-Cheng Hsu; Chun-Hao Tsai
Journal:  BMC Complement Altern Med       Date:  2019-02-04       Impact factor: 3.659

5.  Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways.

Authors:  Bo Zhang; Ling-Ling Yang; Shu-Qin Ding; Jing-Jing Liu; Yan-Hong Dong; Yan-Ting Li; Nan Li; Xiao-Jun Zhao; Chang-Ling Hu; Yiping Jiang; Xue-Qin Ma
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

6.  Enhanced Healthspan in Caenorhabditis elegans Treated With Extracts From the Traditional Chinese Medicine Plants Cuscuta chinensis Lam. and Eucommia ulmoides Oliv.

Authors:  Shimaa M A Sayed; Karsten Siems; Christian Schmitz-Linneweber; Walter Luyten; Nadine Saul
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

7.  A Network Pharmacology-Based Study on Vital Pharmacological Pathways and Targets of Eucommiae Cortex Acting on Osteoporosis.

Authors:  Libo Zhou; Tao Wu
Journal:  Biomed Res Int       Date:  2022-03-31       Impact factor: 3.411

Review 8.  Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.

Authors:  Lichuang Huang; Qiang Lyu; Wanying Zheng; Qiao Yang; Gang Cao
Journal:  Chin Med       Date:  2021-08-06       Impact factor: 5.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.